Our results suggest the existence of a single causal variant in CYP19A1 underlying both E2 concentration and endometrial cancer, although we cannot exclude the possibility that there are instead multiple causal variants which are in sufficiently strong linkage disequilibrium that they are indistinguishable by epidemiological analysis. Here, CYP19A1 is linked to endometrial cancer.